Frontotemporal Lobar Degeneration (FTLD): Clinical Trials

1 trial for Frontotemporal Lobar Degeneration (FTLD), newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 21Completed 1

Follow Frontotemporal Lobar Degeneration (FTLD): new trials by email Literature Review of Frontotemporal Lobar Degeneration (FTLD) trials Research Report on Frontotemporal Lobar Degeneration (FTLD)

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Tau PET Imaging With 18F-AV-1451 in Subjects With MAPT Mutations
18F-AV-1451 - Frontotemporal Lobar Degeneration (FTLD), Frontotemporal Dementia (FTD)
Phase 2CompletedColumbia University72016-04-012019-12-06

Narrower conditions

Frontotemporal Dementia (1)  ·  Frontotemporal Lobar Degeneration (1)  ·  Tauopathies (1)

Broader conditions

Brain Diseases (1)  ·  Central Nervous System Diseases (1)  ·  Dementia (1)  ·  Mental Disorders (1)  ·  Metabolic Diseases (1)  ·  Nervous System Diseases (1)  ·  Neurocognitive Disorders (1)  ·  Neurodegenerative Diseases (1)  ·  Nutritional and Metabolic Diseases (1)  ·  Proteostasis Deficiencies (1)  ·  TDP-43 Proteinopathies (1)

Interventions

7-(6-fluoropyridin-3-yl)-5H-pyrido(4,3-b)indole (1)

Sponsors

Columbia University (1)

Countries

United States (1)

Top investigators

Edward Huey, MD (1)

NIH funding

R01NS076837 (1)